Thymopentin and interleukin-2 in combination with 5-fluorouracil and leucovorin in metastatic colorectal adenocarcinoma: Preliminary results

This publication has 18 references indexed in Scilit:

• Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicity
  Cancer, 1990
• Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignancies
  The Lancet, 1990
• Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes
  International Journal of Immunopharmacology, 1990
• Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
  Journal of Clinical Oncology, 1989
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• Role of chemotherapy in the treatment of colorectal carcinoma
  Seminars in Surgical Oncology, 1987
• The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and α-tocopherol
  European Journal of Cancer and Clinical Oncology, 1982
• Reporting results of cancer treatment
  Cancer, 1981
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958
• Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory Compounds
  Nature, 1957